CClinicalTrials.gg
Status unknownNCT04862871Updated May 11, 2022

Enhancing Analgesia in Chronic Pain Through Exercise

An interventional study of Physical Activity - Pediatric Pain Rehabilitation Center in Pain, Chronic Widespread Pain and Fibromyalgia, sponsored by Boston Children's Hospital. Status unknown at 1 site in United States. Open to participants aged 10 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-11.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
10 Years to 24 Years
Sex
All
01

Study summary

Background: Current pain management strategies for pediatric patients are not integrating the analgesic potential of movement-based therapies. To date, experiencing a painful stimulus has been known to disrupt motor activity in an attempt to minimize injury. However, physical activity, even when it increases ongoing pain initially, has been shown to significantly reduce pain symptoms eventually through neuromodulation. In both acute and chronic pain cohorts, exercise protocols and neuromodulation paradigms have produced exercise-related analgesia. Problem: It is not currently understood which brain regions are implicated in exercise-based analgesia and what brain regions moderate this response.

Approach: The investigators intend to provide a physical activity intervention designed to promote exercise-induced analgesia. This intervention will be performed in a group of pediatric subjects with Chronic Widespread Pain Disorder. An exercise (n=10), no exercise (n=10) and healthy control (n=10) group will be recruited. Aims: This study has three aims: (1) To understand how thermal pain sensitivity, pain symptoms and motor performance are impacted in patients with chronic pain after an exercise-based intervention. (2) To evaluate the brain regions involved in a simple motor task as well as how motor activity influences activity in pain regions of the brain. (3) To evaluate the network structure of the brain, with special emphasis on motor and pain regions, in youth with a pain disorder who have undergone an exercise-based intervention. Exercise-based therapy in pediatric subjects with a chronic pain condition is predicted to reduce pain symptom reporting through biasing activity in pain regions during motor performance. Significance: Findings from this investigation will address the clinical side of pain management strategies and provide potential therapeutic targets and feasibility data. The investigators anticipate that findings will show how pain and motor regions of the brain interact at the network level and if this interaction can be modulated through exercise. Findings will also evaluate the brain regions that mediate the analgesic properties of an exercise-based pain therapy and provide future therapeutic targets.

Read the detailed description

This investigation is aimed at understanding how an exercise program currently performed at the Pediatric Pain Rehabilitation Center (PPRC) at Boston Children's Hospital, designed for individuals with chronic widespread pain is associated with pain relief and how this pain relief relates to changes in the brain. The specific aims/objectives are to explore the following:

Aim 1 - Pain and sensorimotor behavior: To understand how thermal pain sensitivity, pain symptoms and motor performance are impacted in children with chronic pain after an exercise-based intervention. Sensory testing (for Hot \& Cold) will be collected using Quantitative Sensory Testing (QST) to establish pain thresholds. To address motor performance, we will perform the Bruininks-Oseretsky Test (BOT) 1 of motor proficiency (examining muscle power, strength, endurance). Pain symptom levels will be evaluated using self-report questionnaires that address fear of pain, pain catastrophizing, and pain symptom load.

Aim 2 - Defining hierarchies during motor performance: To evaluate the brain regions involved in a simple motor task as well as how motor activity influences activity in pain regions. Participants will perform a tapping task within the MRI scanner to evaluate the brain regions that are active during motor control. 2 Functional magnetic resonance images will be processed using dynamic causal modeling (DCM) to evaluate effective connectivity (Figure 2) during task performance. Brain regions evaluated in DCM will be defined by the healthy control cohort.

Aim 3 - Network structure: To evaluate the network structure of the brain, with emphasis on motor and pain regions, in persons with a pain disorder who have undergone an exercise intervention. Graph theory analyses implemented using resting-state functional magnetic resonance imaging will be performed to extract metrics reflecting network efficiency, nodal degree, and nodal centrality. Structural metrics (e.g., cortical thickness and white matter connectivity) will be collected as nuisance variables. Correlation analyses will be performed between network metrics and behavior (fear of pain, pain catastrophizing, motor performance) to evaluate their influence over network reorganization observed from the exercise intervention. Brain regions that define canonical pain and motor networks will be indexed from the healthy control group.

02

Conditions studied

  • Pain
  • Chronic Widespread Pain
  • Fibromyalgia
03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 265 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 1,034 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 598 studies on the registry; 151 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Otherwise healthy participants between the ages of 10 and 24
  • Actively on the waitlist for, or having completed the exercise program at the PPRC
  • Comprehension of instructions
  • Parental consent for minors
  • Weight less than 250 lbs - limit of MRI table
  • Clinical diagnosis of Chronic Widespread Pain

Exclusion criteria

Exclusion Criteria:

  • Preventative medications and opioids
  • Metallic implants that will pose harm to the subject (e.g., pacemaker) and/or affect the dat (e.g., braces)
  • Significant medical disease (systemic or CNS).
  • Active suicidality, psychosis, diagnosed eating disorders, and/or other severe clinically diagnosed neuro-psychiatric conditions
  • Pregnant
  • Claustrophobia
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • No intervention
    Healthy Controls

    A cohort (n=10) of participants will be recruited who do not have any neurological conditions and are age and sex-matched to participants in Arms 2 and 3.

  • No intervention
    Chronic Widespread Pain

    A cohort (n=10) of participants who have not yet begun the exercise program and are currently on the waitlist for the exercise program at the PPRC

  • Active comparator
    Chronic Widespread Pain - Exercise

    A cohort (n=10) of participants who have completed the exercise program at the PPRC. These individuals will be evaluated the day of their last treatment visit

    Behavioral: Physical Activity - Pediatric Pain Rehabilitation Center

Interventions

  • BehavioralPhysical Activity - Pediatric Pain Rehabilitation Center

    While admitted to the Pediatric Pain Rehabilitation Center program, patients receive 1-3 hours of individual and group physical therapy 5 times per week and completed a 30-60 minute home exercise program 9 times per week. The median length of stay for the program is 5 weeks. The amount of aerobic exercise prescribed is individualized to each patient and ranged from 10-20 minutes per session. The duration of aerobic exercise prescribed progressed by 5-10 min weekly until the child reached 20-30 minutes. Patients are instructed to reach a moderate to vigorous intensity of exercise (defined at 5-7/10 rate of perceived exertion). The mode of exercise varied dependent on patient ability and interest. Typical modes of exercise included: walking, running, stationary biking, swimming, sports (i.e., soccer, dance), and online aerobic workouts. Patients were prescribed an individualized 30-60 minute discharge home program using the same structure upon completing the program.

06

What researchers measure

Primary outcomes

  1. Change in effective connectivity

    Difference in effective connectivity between motor and pain regions of the brain between persons who have completed the PPRC intervention and those on the waitlist. Whole-brain effective connectivity will be evaluated and compared between groups that will be age and sex-matched. Effective connectivity will be calculated using dynamic causal modeling and evaluated using a tapping task. Effective connectivity will be calculated from a motor task requiring participants to complete an active (tapping) and rest (no tapping) condition.

    Time frame: 8 months

Secondary outcomes

  1. Thermal sensitivity

    Quantitative sensory testing (QST) will be used to evaluate thermal sensitivity to hot and cold stimulus paradigms. The outcome measure of interest will be participants self-reported pain ratings using a visual analogue scale (VAS) from 0 (minimum - no pain) to 10 (maximum - high pain) at specific levels of thermal sensitivity.

    Time frame: 8 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There are currently no plans to share individual participant data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04862871
Lead sponsor
Boston Children's Hospital
Responsible party
Scott Holmes (Research Associate, Boston Children's Hospital) — Principal investigator
First posted
Apr 28, 2021
Start date
Apr 1, 2022
Primary completion
Aug 2022 (estimated)
Completion
Nov 2022 (estimated)
Last update
May 11, 2022

Study contacts

Scott Holmes, PhD
Contact
scott.holmes@childrens.harvard.edu
6179196648
Scott Holmes, PhD
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion